- Ensure the correct functioning of the site
- Provide you the best service
- Enhance your user experience
- Optimize our website
Learn more in cookies statement & settings
We are excited to share with you the new dates for the 2022 JUMPstart program which is planned on-site in Germany!
The JUMPstart program will gather 20 participants from around the world and the JUMPstart Scientific Committee, led by Prof. Mette Berger (Switzerland), will equip you with profound insights into designing, budgeting, performing, evaluating and publishing clinical studies along with experience sharing based on their years of expertise in the field of clinical nutrition research. The program will take place again in Germany, and will be divided in:
Basic Module: December 10th & 11th, 2022
Advanced Module: February 11th & 12th, 2023
Both interactive modules are led by the 5 members of the JUMPstart Scientific Committee. The interactive sessions are packed with information on how to perform research in clinical nutrition with a special focus on critically ill patients and patients after major surgery.
During the JUMPstart program you'll have the opportunity to further develop your research idea up to a solid study proposal and apply for the € 250.000 JUMPstart Research Grant to support your investigation and benefit your healthcare organization. The research proposal can come from the following areas:
The travel and accommodation costs may be covered by Fresenius Kabi (subject to additional local laws, regulations, and industry code requirements specified in the JUMPstart agreement, which may require the participant to cover costs of travel and accommodation costs and/or pay a participation fee). Healthcare professionals from the United States selected for JUMPstart must cover their own travel and accommodation costs and pay a $500 registration fee for participation in JUMPstart.
Using this link will let you leave a website of Fresenius Kabi Deutschland GmbH (“Fresenius Kabi”) or to a different domain under the control of Fresenius Kabi. In the event that the linked site is not under the control of Fresenius Kabi but under the control of a third party or an affiliate in the Fresenius group of companies, Fresenius Kabi shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Fresenius Kabi of the site.
Do you want to continue?